Equifax Inc. stock dropped 6% last week to $191 per share following investor reassessments of its valuation after Q4 2025 earnings, which, despite beating guidance, triggered analyst price target reductions. JPMorgan, Royal Bank of Canada, Wells Fargo, and Needham all lowered their targets, though overall analyst sentiment remains a “Moderate Buy.” A valuation model, anticipating 9.5% revenue growth and 22.4% operating margins, projects a target price of $295, suggesting the stock is currently undervalued with a 54% upside.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Equifax Fell 6% Last Week. Here’s Where the Stock Could Head in 2026
Equifax Inc. stock dropped 6% last week to $191 per share following investor reassessments of its valuation after Q4 2025 earnings, which, despite beating guidance, triggered analyst price target reductions. JPMorgan, Royal Bank of Canada, Wells Fargo, and Needham all lowered their targets, though overall analyst sentiment remains a “Moderate Buy.” A valuation model, anticipating 9.5% revenue growth and 22.4% operating margins, projects a target price of $295, suggesting the stock is currently undervalued with a 54% upside.